Cargando…
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
BACKGROUND: Myxoid liposarcoma is a relatively common malignant soft tissue tumor, characterized by a (12;16) translocation resulting in a FUS-DDIT3 fusion gene playing a pivotal role in its tumorigenesis. Treatment options in patients with inoperable or metastatic myxoid liposarcoma are relatively...
Autores principales: | Willems, Stefan M, Schrage, Yvonne M, Bruijn, Inge H Briaire-de, Szuhai, Karoly, Hogendoorn, Pancras CW, Bovée, Judith VMG |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955617/ https://www.ncbi.nlm.nih.gov/pubmed/20863376 http://dx.doi.org/10.1186/1476-4598-9-257 |
Ejemplares similares
-
Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples
por: de Jong, Danielle, et al.
Publicado: (2011) -
Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019) -
Histological response to radiotherapy is an early event in myxoid liposarcoma
por: Lam, Suk Wai, et al.
Publicado: (2023) -
Genome-wide analysis of Ollier disease: Is it all in the genes?
por: Pansuriya, Twinkal C, et al.
Publicado: (2011) -
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)